MENU
+Compare
PRTG
Stock ticker: NASDAQ
AS OF
Jun 26, 04:59 PM (EDT)
Price
$6.05
Change
-$0.06 (-0.98%)
Capitalization
13.87M

PRTG Portage Biotech Inc Forecast, Technical & Fundamental Analysis

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs... Show more

PRTG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PRTG with price predictions
Jun 25, 2025

PRTG in upward trend: price expected to rise as it breaks its lower Bollinger Band on June 11, 2025

PRTG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 46 cases where PRTG's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PRTG's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PRTG advanced for three days, in of 234 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PRTG as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PRTG turned negative on June 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

PRTG moved below its 50-day moving average on June 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PRTG crossed bearishly below the 50-day moving average on June 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRTG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PRTG entered a downward trend on June 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PRTG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.921) is normal, around the industry mean (16.539). P/E Ratio (0.173) is within average values for comparable stocks, (59.016). PRTG's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.605).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRTG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PRTG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRTG is expected to report earnings to fall 88.30% to -21 cents per share on August 15

Portage Biotech Inc PRTG Stock Earnings Reports
Q1'24
Est.
$-0.22
Q4'23
Missed
by $1.61
Q3'23
Missed
by $0.02
Q2'23
Missed
by $0.95
Q1'23
Missed
by $5.07
The last earnings report on February 28 showed earnings per share of -187 cents, missing the estimate of -27 cents. With 45.96K shares outstanding, the current market capitalization sits at 13.87M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Clarence Thomas Building
Phone
+1 203 221-7378
Employees
7
Web
https://www.portagebiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTVA0.680.01
+1.18%
MetaVia Inc
AUNA6.270.02
+0.32%
Auna SA
VRSN282.44-2.59
-0.91%
VeriSign
ACU39.54-0.39
-0.98%
Acme United Corp
UNF184.61-3.62
-1.92%
Unifirst Corp

PRTG and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTG has been loosely correlated with AMGXF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTG jumps, then AMGXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTG
1D Price
Change %
PRTG100%
+13.57%
AMGXF - PRTG
34%
Loosely correlated
N/A
NBY - PRTG
34%
Loosely correlated
-0.64%
PRLD - PRTG
27%
Poorly correlated
-2.43%
CVAC - PRTG
26%
Poorly correlated
+1.49%
JSPR - PRTG
26%
Poorly correlated
-0.09%
More